These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 397765)

  • 1. Thromboxane A2 biosynthesis during endotoxin-induced aggregation of platelets from normal and sensitized guinea-pigs.
    Bult H; Herman AG
    Agents Actions; 1979 Dec; 9(5-6):560-5. PubMed ID: 397765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of thromboxane A2 in endotoxin-induced aggregation of guinea-pig platelets in vitro.
    Bult H; Herman AG
    Agents Actions Suppl; 1979; (4):147-55. PubMed ID: 386740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biosynthesis of prostaglandins and thromboxane in the blood platelets].
    Katori M
    Nihon Rinsho; 1978 Dec; 36(12):3805-12. PubMed ID: 372618
    [No Abstract]   [Full Text] [Related]  

  • 4. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin inhibits the formation of endoperoxide metabolites in rat platelets: aspirin-like activity.
    Hwang DH; LeBlanc P
    Prostaglandins Med; 1981 Apr; 6(4):341-4. PubMed ID: 7280114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase.
    Lagarde M; Byron PA; Vargaftig BB; Dechavanne M
    Br J Haematol; 1978 Feb; 38(2):251-66. PubMed ID: 205238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA; Gorman RR
    Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thromboxane antagonist EP 045 on platelet aggregation.
    Jones RL; Wilson NH; Armstrong RA; Peesapati V; Smith GM
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():345-50. PubMed ID: 6303074
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin-mediated inhibition of human platelet aggregation.
    Saba HI; Saba SR; Morelli G; Hartmann RC
    Thromb Res; 1984 Apr; 34(1):19-33. PubMed ID: 6328692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ethanol on thromboxane synthesis by blood platelets.
    Pennington SN; Smith CP
    Prostaglandins Med; 1979 Jan; 2(1):43-50. PubMed ID: 575859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation and thromboxane A2 formation in cat platelet rich plasma.
    Marcinkiewicz E; Grodzińska L; Gryglewski RJ
    Pharmacol Res Commun; 1978 Jan; 10(1):1-12. PubMed ID: 643889
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of TXA2 formed by blood platelets and PGX formed by blood vessels and formation of thrombi].
    Srivastava KC
    Ugeskr Laeger; 1977 Nov; 139(47):2815-6. PubMed ID: 339456
    [No Abstract]   [Full Text] [Related]  

  • 20. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.